See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical

Summary by Charleston Gazette-Mail
ALPHARETTA, Ga., July 31, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a privately held company based in Raleigh, NC.

42 Articles

Bennington BannerBennington Banner
+41 Reposted by 41 other sources
Center

Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical

ALPHARETTA, Ga., July 31, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a privately held company based in Raleigh, NC.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 68% of the sources are Center
68% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Thursday, July 31, 2025.
Sources are mostly out of (0)

Similar News Topics

Alpharetta icon

Alpharetta

News
For You
SearchBlindspotLocal